Quick wits saved a man’s life last month when a crane boom came down onto him in Nanjing UK rental company Clearview has ordered three Ruthmann truck mounted platforms US crane rental company Crane Service Inc has ordered another Liebherr LG 1800-1.0 wheeled lattice crane Haulotte has appointed Guillaume Van Hoeck as managing director Europe Czech crane rental company AG Transport has ordered an 800t LR 1800-1.0 lattice crawler German sales and rental company Kunze has added Elma cranes to its portfolio This website is using a security service to protect itself from online attacks The action you just performed triggered the security solution There are several actions that could trigger this block including submitting a certain word or phrase You can email the site owner to let them know you were blocked Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page German daily newspaper Handelsblatt said the divestment plans had been delayed due to the need to restructure operations following the company’s acquisition of the finished drug product manufacturing business of Switzerland’s Vifor in 2021 The deal included three production facilities in Fribourg und Ettingen ICIG has hired investment bank William Blair to handle the sale that could potentially value the drugmaker at around €2.5 billion Big name private equity investors such as Bain EQT and Permira are thought to be interested in at least studying the prospect Corden has declined to comment on the mooted sale plans Following the expected divestment of the pharma asset ICIG is seen as planning to focus on its chemicals holdings which include CMO WeylChem and PVC producer Vynova as well as CarboTech synthetic fiber composites maker Enka and Rütgers Organics In recent months, CordenPharma has been steadily expanding its asset base the company announced it would spend nearly €10 million on a new GMP facility at its Plankstadt campus for oral solid drugs to be used in clinical trials It also invested in the expansion of production in the US state of Colorado and at Chenôve and signed a deal with Germany’s Wacker Chemie to jointly develop knowhow and processes for manufacturing lipid nanoparticles (LNP) In its first project of 2022, the company announced a collaboration with PeptiSystems a Swedish developer of instruments for peptide and oligonucleotide therapeutic process development and manufacturing based on flow through column technology At its peptide center of excellence in Frankfurt CordenPharma has introduced PeptiSystems’ innovative solution to reduce the environmental impact of its Process Mass Intensity (PMI) of peptide manufacturing processes thereby reducing solvent consumption and waste by at least 40% in all peptides produced by Solid-Phase Peptide Synthesis (SPPS) Are you ready to elevate your pharmaceutical operations Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis